Bayer

“223. The Revealing Summary Reversal in LULAC: Monday’s One-Paragraph Order in the Texas Redistricting Case Is Both a Procedural Anomaly and a Sharp Rejoinder to Those Who Still Use the ‘Interim’ Label to Refer to the Emergency Docket.”

ALX Oncology Presents P-I/II Trial Data on Evorpacept Combination in Metastatic Breast Cancer (mBC) at ESMO Breast Cancer’26

Pharma 5.0, Sustainability & Security: PHARMAP 2026 Brings Pharma’s Future Into Focus

Keep an Eye on These 15 Biotech Companies in 2026 

4 Spaces Primed for the Next Wave of Gene Therapies

Robotic Security Dogs Now on the Job to Protect Crops

STAT+: Novo Nordisk’s Less-Bad News on Its Wegovy Pill Boosts Earnings and Share Price

Biotech in 2025: A Retrospective 

ZDA Promotes Zambia’s Investment Potential During High-Level Germany Engagements

Daybreak May 4: U.S.-EU Trade Tensions Flare – Again

Beacon Therapeutics Reports P-II (DAWN) Trial Data on Laru-Zova in X-Linked Retinitis Pigmentosa (XLRP)

Iridius Raises $8.6M Seed Round to Build Compliance-by-Design AI Platform for Regulated Enterprise Workflows

Microplastics and Pharmaceuticals Named a Priority Threat in Drinking Water by Health, Environment Officials

TerraPower Commits $450M to Build Radioisotope Production Plant

Bayer and Bp Team up to Scale Camelina Crop for Sustainable Aviation Fuel

Apple Names Eva Yao Marketing Communications Director for Greater China

The 5 Largest IPOs in Biopharma History

Telix, Regeneron Ink $40M 50/50 Deal to Co‑Develop Next‑Gen Radiopharmaceuticals

Seeds of Power: China Turns to Genetic Engineering to Become Global Superpower

China’s X-Humanoid Raises $100M in First Funding Round

Leading Carbon Credit Registries Expand Into Supply-Chain Decarbonization

Bayer Ends Multi-Year M&A Drought with up to $2.45B Perfuse Buy

Why Duluth Trusts AI Agents with Bidding, but Not Brand Storytelling

Campaigners Call for Ban on Use of Weedkiller Glyphosate at Harvest Time

ASCO 2026: Bayer to Present New Data Across Oncology Portfolio

Pharmaceutical Executive Daily: Zentalis Doses First Patient with Azenosertib in Phase III Trial

Immunotherapy Drug Helps Bladder Cancer Patients Avoid Major Organ Removal

To Glyphosate Or Not To Glyphosate — That Is The Question

How Bayer Uses AI to Avoid Sending Customers to Its Competition

Interview: Bernard Seiser, Vice-President of Digital, Data and IT, AOP Health

Pharma and Biotech M&As 2026 Deal Watcher

“Why Trump’s Winning Streak at the Supreme Court Came to an Abrupt End; The Trump Administration Won a Series of High-Profile Victories Last Year, but the President Has Made Fewer Emergency Appeals and Is Facing Losses on His Signature Policies”

Modicus Prime Announces $8M in Funding to Enable AI Audit Readiness Across Pharma

As EU-Mercosur Agreement Goes Into Effect, Environmentalists Raise Red Flags

CPI Inflation Rate Heats Up to +3.8%

What Makes Veeva Systems Inc (VEEV)’s Future Bright?

Calcium Score Predictive of ASCVD Risk From Elevated Lp(a)

Corsa Digital Expands Into CTV, Appoints Carlo Robles to Lead Programmatic Growth

HSBC Picks Harvey AI for Lawful Good Plans

Justices to Hear Dispute over Cancer Warnings on Pesticide Labels

Verner Panton:Form, Colour, Space

Participating Faculty: Clinical Management and Economic Drivers of Heart Failure With Preserved or Mildly Reduced Ejection Fraction

Loper Bright and Preemption

Inner AI Raises $6M Seed Round

BridgeBio’s Attruby Challenges Pfizer’s Vyndamax Legacy in Pivotal ATTR Trial

Rescued by the Welder’s Whip and Anchored by the Painter’s Spray Gun

FDA Clears Low-Dose MRI Contrast Agent Vueway for Newborns and Infants

MAHA Scores on Farm Bill but Loses Ally for Surgeon General

Women Have Awaited a Revolution in Menopause. It Hasn’t Arrived.

Bayer to Make 'Careful but Aggressive' Return to Pharma M&A, CEO Says

Bayer to Acquire Perfuse Therapeutics in $2.45B Deal

Voyageur Pharmaceuticals Secures Up to $2.35M Funding From Bayer

WellTheory Raises $14M Series A Led by General Catalyst

WellTheory Raises $14M Series A Led by General Catalyst to Fuel Growth and AI Development